Title: The role of TP, TS, and DPD as potential predictors of outcome following capecitabine plus oxaliplatin (XELOX) versus bolus 5-fluorouracil/leucovorin (5-FU/LV) as adjuvant therapy for stage III colon cancer: Biomarker findings from study NO16968 (XELOXA)
Authors: Schmoll, Hans-Joachim
Tabernero, Josep
Alfred Maroun, Jean
De Braud, Filippo G
Jay Price, Timothy
Van Cutsem, Eric
Hill, Mark
Hoersch, Silke
Rittweger, Karen
Chen, David
Haller, Daniel G
Issue Date: 2012
Publisher: Grune & Stratton
Host Document: Journal of Clinical Oncology vol:30 issue:15
Conference: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) location:Chicago: IL date:JUN 01-06, 2012
ISSN: 0732-183X
Publication status: published
KU Leuven publication type: IMa
Appears in Collections:Clinical Digestive Oncology (+)

Files in This Item:

There are no files associated with this item.


All items in Lirias are protected by copyright, with all rights reserved.